Product logins

Find logins to all Clarivate products below.


chevron_left

Sizing the non-small-cell lung cancer (NSCLC) market with trusted epidemiology data

Thought Leadership
Sizing the non-small-cell lung cancer (NSCLC) market with trusted epidemiology data

Exploring in-depth patient population insights in the fast-growing NSCLC market.

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, and represents one of the largest oncology therapy markets. In this infographic, Clarivate experts provide a snapshot of NSCLC epidemiology data, including:

  • Projected market size by 2032
  • Granular patient population by stage at diagnosis
  • Top comorbidities based on U.S. claims-based data
  • Insights into drug-treated vs non-drug treated populations

Related insights

The latest news, technologies, and resources from our team.

EU Large-Joint Reconstructive Implants EU Large-Joint Reconstructive Implants
EU Large-Joint Reconstructive Implants
Oncology Drugs to Watch: ASCO 2025 Highlights
Six emerging U.S medical cost and access drivers to watch in 2025-2026
chevron_left
chevron_right